175 related articles for article (PubMed ID: 7622930)
21. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
Chen XS; Li WZ; Jiang C; Ye GY
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
[TBL] [Abstract][Full Text] [Related]
22. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
24. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
[TBL] [Abstract][Full Text] [Related]
25. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
[TBL] [Abstract][Full Text] [Related]
26. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
[TBL] [Abstract][Full Text] [Related]
27. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):195-201. PubMed ID: 7602214
[TBL] [Abstract][Full Text] [Related]
28. Relapse of leprosy after multidrug therapy.
Dasananjali K
J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
[TBL] [Abstract][Full Text] [Related]
29. Pure neuritic leprosy in India: an appraisal.
Kumar B; Kaur I; Dogra S; Kumaran MS
Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):284-90. PubMed ID: 15485285
[TBL] [Abstract][Full Text] [Related]
30. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
31. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
32. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
33. Multibacillary nerve histology in clinically diagnosed borderline tuberculoid leprosy patients.
Ebenezer GJ; Suneetha S; Mohandas R; Arunthathi S
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):311-5. PubMed ID: 8862266
[TBL] [Abstract][Full Text] [Related]
34. Relapses vs. reactions in multibacillary leprosy: proposal of new relapse criteria.
Linder K; Zia M; Kern WV; Pfau RK; Wagner D
Trop Med Int Health; 2008 Mar; 13(3):295-309. PubMed ID: 18397393
[TBL] [Abstract][Full Text] [Related]
35. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
[TBL] [Abstract][Full Text] [Related]
36. A study of relapse after MDT in a district in West Bengal, India.
Haldar A; Mahapatra BS; Mundle M; Haldar S; Saha AK
Indian J Lepr; 2003; 75(1):1-8. PubMed ID: 15253389
[TBL] [Abstract][Full Text] [Related]
37. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
[TBL] [Abstract][Full Text] [Related]
39. Clinical analysis of multibacillary leprosy patients after 1-year fixed World Health Organization recommended multidrug therapy at Yangon General Hospital, Myanmar.
Kyaw K; Tsoh TM; Swe SY; Nagaoka Y; Takezaki S; Suzuki K; Ishii N
J Dermatol; 2008 May; 35(5):264-9. PubMed ID: 18477225
[TBL] [Abstract][Full Text] [Related]
40. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
